W 434 (Pantoprazole sodium delayed release 40 mg)
Pill imprint W 434 has been identified as Pantoprazole sodium delayed release 40 mg.
Pantoprazole is used in the treatment of gerd; barrett's esophagus; dumping syndrome; erosive esophagitis; duodenal ulcer (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Pantoprazole 40 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).
- 40 mg
- Elliptical / Oval
- Prescription only
silicon dioxide colloidal
sodium starch glycolate type A potato
polyethylene glycol 4000
ferric oxide yellow
FD&C Blue No. 2
methacrylic acid - ethyl acrylate copolymer (1:1) type a
polyethylene glycol 400
polyethylene glycol 6000
ferric oxide red
More about pantoprazole
- Pantoprazole delayed-release tablets
- Pantoprazole suspension
- Pantoprazole (Advanced Reading)
- Pantoprazole Intravenous (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.